Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview
Drug Discovery
Importance of Cell-based Assays
Cell Signaling Pathways
Mechanisms of Drug Action
Gene Expression Regulation
Cytotoxicity and Viability
Disease Modeling
Types of Cell-based Assays
Cell Viability Assays
Cell Proliferation Assays
Cytotoxicity Assays
Application of Cell-based Assays
Drug Discovery and Development
Toxicology Studies
Cancer Research
Infectious Disease Research
Immunology and Inflammation
Molecular Pathway Analysis
Regenerative Medicine and Tissue Engineering
Biomarker Discovery and Validation
Precision and Personalized Medicine

Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Chronic Diseases
Rising Demand for Drug Discovery and Development
High Demand for Personalized Medicine
Increasing Investment in Drug R&D
Market Restraints
High Cost of Assay Development and Maintenance
Technical Challenges and Complexity
Short Shelf-life of Reagents and Consumables
Market Opportunities
Expanding Applications in Drug Discovery
Expansion in Diagnostics and Biomarker Discovery

Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
CRISPR/Cas9 Technology
High-content Screening (HCS) and Imaging
AI and Machine Learning (ML) in Data Analysis
Patent Analysis
Patent Review, by Leading Jurisdiction

Chapter 5 Market Segmentation Analysis
Overview
Segmentation Breakdown
Cell-based Assays: Global Markets
Market Analysis by Product Type
Consumables
Instruments
Software
Services
Market Analysis by Application
Drug Discovery
Absorption, Distribution, Metabolism, and Excretion (ADME)/Toxicity
Basic Research
Market Analysis by End User
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence
Competitive Landscape
Ranking of Companies in the Cell-based Assay Market

Chapter 7 Sustainability in Cell-based Assay Market: An ESG Perspective
Sustainability in the Cell-based Assay Market
Animal Testing
Miniaturization and Automation
Green Chemistry and Eco-friendly Materials
3D Cell Cultures and Tissue Models
Waste Reduction and Optimization of Resources
Improving Drug Discovery Efficiency
ESG Risks and Ratings: Understanding the Data

Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
BIOIVT
BIO-RAD LABORATORIES INC.
CELL BIOLABS INC.
CELL BIOLOGICS INC.
CHARLES RIVER LABORATORIES
DANAHER CORP.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
LONZA
MERCK KGAA
PROMEGA CORP.
REVVITY
THERMO FISHER SCIENTIFIC INC.



List of Figures

List of Figures
Summary Figure A : Global Market for Cell-based Assays, by Product Type, 2021-2029
Summary Figure B : Global Market for Cell-based Assays, by Region, 2021-2029
Figure 1 : Projected Global Aging Population (65 Years and Above), 1990-2050
Figure 2 : Drug Discovery Process Steps
Figure 3 : Market Dynamics of Cell-based Assays
Figure 4 : FDA Approval of Personalized Medicines, 2015-2022
Figure 5 : Pharmaceutical R&D Spending, by Country/Region, 2010-2022
Figure 6 : Shares of Global Market for Cell-based Assays, by Product Type, 2023
Figure 7 : Shares of Global Market for Cell-based Assays, by Application, 2023
Figure 8 : Shares of Global Market for Cell-based Assays, by End User, 2023
Figure 9 : R&D Spending of Biopharmaceutical Companies, 2010-2024
Figure 10 : Shares of Global Market for Cell-based Assays, by Region, 2023
Figure 11 : Shares of North American Market for Cell-based Assays, by Country, 2023
Figure 12 : Shares of European Market for Cell-based Assays, by Country, 2023
Figure 13 : Shares of Asia-Pacific Market for Cell-based Assays, by Country, 2023
Figure 14 : Shares of RoW Market for Cell-based Assays, by Subregion, 2023
Figure 15 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 16 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2024
Figure 18 : BD: Revenue Share, by Country/Region, FY 2024
Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 22 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 25 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 26 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 27 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 28 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 29 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 30 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 31 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 32 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 33 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023

List of Tables

List of Tables
Summary Table A : Global Market for Cell-based Assays, by Product Type, Through 2029
Summary Table B : Global Market for Cell-based Assays, by Region, Through 2029
Table 1 : Factors in Cell-based Assay Development
Table 2 : Types of Cellular Assays
Table 3 : New Cases and Deaths Due to Selected Cancers Globally, 2022
Table 4 : U.S. NIH Funding for Selected Diseases, 2019–2023
Table 5 : Existing Cell-based Assay Technologies
Table 6 : Patents Issued for Cell-based Assays, by Jurisdiction, 2022-2024
Table 7 : Global Market for Cell-based Assays, Through 2029
Table 8 : Global Market for Cell-based Assays, by Product Type, Through 2029
Table 9 : Global Market for Cell-based Assays, by Application, Through 2029
Table 10 : Global Market for Cell-based Assays, by End User, Through 2029
Table 11 : Global Market for Cell-based Assays, by Region, Through 2029
Table 12 : North American Market for Cell-based Assays, by Country, Through 2029
Table 13 : European Market for Cell-based Assays, by Country, Through 2029
Table 14 : Asia-Pacific Market for Cell-based Assays, by Country, Through 2029
Table 15 : RoW Market for Cell-based Assays, by Subregion, Through 2029
Table 16 : Ranking of Companies in Cell-based Assay Market, 2023
Table 17 : ESG Rankings for Major Cell-based Assay Companies, 2024*
Table 18 : Information Sources in This Report
Table 19 : Abbreviations Used in this Report
Table 20 : Agilent Technologies Inc.: Company Snapshot
Table 21 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 22 : Agilent Technologies Inc.: Product Portfolio
Table 23 : Agilent Technologies Inc.: News/Key Developments, 2024
Table 24 : BD: Company Snapshot
Table 25 : BD: Financial Performance, FY 2023 and 2024
Table 26 : BD: Product Portfolio
Table 27 : BD: News/Key Developments, 2024
Table 28 : BioIVT: Company Snapshot
Table 29 : BioIVT: Product Portfolio
Table 30 : BioIVT: News/Key Developments, 2023 and 2024
Table 31 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 32 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 33 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 34 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 35 : Cell Biolabs Inc.: Company Snapshot
Table 36 : Cell Biolabs Inc.: Product Portfolio
Table 37 : Cell Biologics Inc.: Company Snapshot
Table 38 : Cell Biologics Inc.: Product Portfolio
Table 39 : Charles River Laboratories: Company Snapshot
Table 40 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 41 : Charles River Laboratories: Product Portfolio
Table 42 : Charles River Laboratories: News/Key Developments, 2023 and 2024
Table 43 : Danaher Corp.: Company Snapshot
Table 44 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 45 : Danaher Corp.: Product Portfolio
Table 46 : Fujifilm Holdings Corp.: Company Snapshot
Table 47 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 48 : Fujifilm Holdings Corp.: Product Portfolio
Table 49 : GE Healthcare: Company Snapshot
Table 50 : GE Healthcare: Financial Performance, FY 2022 and 2023
Table 51 : GE Healthcare: Product Portfolio
Table 52 : Lonza: Company Snapshot
Table 53 : Lonza: Financial Performance, FY 2022 and 2023
Table 54 : Lonza: Product Portfolio
Table 55 : Lonza: News/Key Developments, 2021
Table 56 : Merck KGaA: Company Snapshot
Table 57 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 58 : Merck KGaA: Product Portfolio
Table 59 : Promega Corp.: Company Snapshot
Table 60 : Promega Corp.: Product Portfolio
Table 61 : Promega Corp.: News/Key Developments, 2023
Table 62 : Revvity: Company Snapshot
Table 63 : Revvity: Financial Performance, FY 2022 and 2023
Table 64 : Revvity: Product Portfolio
Table 65 : Revvity: News/Key Developments, 2023 and 2024
Table 66 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 67 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 68 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 69 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024